Leap-in to the Future of Cell-Line Development
Presented by Chrysanthi Sitmalidou, Scientist II at Orchard Therapeutics
Panellists
- Metewo Selase Enuameh, Senior Scientist, REGENXIBIO
Session Discussion Points
-
Advancements in Cell-Line Development: new technologies and applications
-
Automation Gaps in Cell-Line Development Workflows
-
Next-Generation Cell Line Development: Higher Titres- Shorter Timelines
Register Interest
Speaker Bio
Chrysanthi is a seasoned scientist with a background in Cell Line Development, Viral Vector Upstream Process Development, and Molecular & Cellular Biology. Holding a Master of Science degree from Brunel University London, she brings over four years of industrial experience to the table. Motivated and dedicated, Chrysanthi is known for her strong work ethic and collaborative spirit, making her a valuable asset in the field of process development.
Innovations in Bioprocessing for Advanced Therapies
- Process Intensification & Optimisation
- Single-Use Bioprocessing Platforms
- Advanced Analytical Technologies
- Continuous Bioprocessing
Quality Assurance for Cell & Gene Therapies
- Analytical Methods e.g., Potency Assays
- In-Process Controls
- Regulatory Compliance
- Release Testing
Addressing the Challenges of Cell and Gene Therapy Translation: From Lab to Patient
- Preclinical R&D
- Clinical Development Pathway
- Patient Access & Advocacy
- Industry/Academic/Healthcare Collaboration
Unlocking the Potential of AAV Gene Therapy: Challenges, Innovations, and Future Directions
- Vector Engineering
- Delivery Challenges & Innovations
- Scalability & Manufacturing
Advancing Cell Culture Technology & Media
- Serum vs. Serum-Free Media
- Cell Culture Conditions & Parameters
- Quality vs. Quantity
- Single-Use vs. Reusable Systems
Process Challenges in ATMP Development: Overcoming Hurdles for Successful Manufacturing
- Scalability & Manufacturing Complexity
- Supply Chain Management & Logistics
- Regulatory Compliance & Quality Assurance